相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected
Francesco Ferrara et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)
Healthcare Systems across Europe and the US: The Managed Entry Agreements Experience
Michele Ciulla et al.
HEALTHCARE (2023)
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study
Francesco Ferrara et al.
CLINICAL DRUG INVESTIGATION (2022)
Scientific Hypothesis for Treatment of COVID-19′s Lung Lesions by Adjusting ACE/ACE2 Imbalance
F. Ferrara et al.
CARDIOVASCULAR TOXICOLOGY (2021)
Medicines shortages and the perception of healthcare professionals working in hospitals: An Italian case study
Andrea Zovi et al.
Journal of Interprofessional Education and Practice (2021)
Logistics management provides greater efficiency, governance and compliance
Francesco Ferrara et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy
Entela Xoxi et al.
FRONTIERS IN PHARMACOLOGY (2021)
Managed Entry Agreements: Policy Analysis From the European Perspective
Monique Dabbous et al.
VALUE IN HEALTH (2020)
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
Rick Vreman et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Francesco Ferrara et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future
Kim Pauwels et al.
FRONTIERS IN PHARMACOLOGY (2017)
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study
Sabine Vogler et al.
LANCET ONCOLOGY (2016)
MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY
Simona Montilla et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2015)
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Jakub Adamski et al.
BMC HEALTH SERVICES RESEARCH (2010)